522 related articles for article (PubMed ID: 1905328)
1. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
[TBL] [Abstract][Full Text] [Related]
2. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.
D'Urso CM; Wang ZG; Cao Y; Tatake R; Zeff RA; Ferrone S
J Clin Invest; 1991 Jan; 87(1):284-92. PubMed ID: 1898655
[TBL] [Abstract][Full Text] [Related]
3. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
4. Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells.
Wang Z; Arienti F; Parmiani G; Ferrone S
Eur J Immunol; 1998 Sep; 28(9):2817-26. PubMed ID: 9754569
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.
Ma D; Niederkorn JY
Immunology; 1995 Oct; 86(2):263-9. PubMed ID: 7490128
[TBL] [Abstract][Full Text] [Related]
6. Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.
Stam NJ; Kast WM; Voordouw AC; Pastoors LB; van der Hoeven FA; Melief CJ; Ploegh HL
J Immunol; 1989 Jun; 142(11):4113-7. PubMed ID: 2541206
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells.
Wang Z; Hu XZ; Tatake RJ; Yang SY; Zeff RA; Ferrone S
Cancer Res; 1993 Sep; 53(18):4303-9. PubMed ID: 7689931
[TBL] [Abstract][Full Text] [Related]
8. High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells.
Versteeg R; Peltenburg LT; Plomp AC; Schrier PI
J Immunol; 1989 Dec; 143(12):4331-7. PubMed ID: 2512356
[TBL] [Abstract][Full Text] [Related]
9. Modulation by cytokines of HLA antigens, intercellular adhesion molecule 1 and high molecular weight melanoma associated antigen expression and of immune lysis of clones derived from the melanoma cell line MeM 50-10.
Maio M; Gulwani B; Tombesi S; Ferrone S
Cancer Immunol Immunother; 1989; 30(1):34-42. PubMed ID: 2513111
[TBL] [Abstract][Full Text] [Related]
10. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
11. [Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-gamma regulatory effect].
Zhang C; Tian Z; Hou G
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):369-72. PubMed ID: 11810763
[TBL] [Abstract][Full Text] [Related]
12. Distinct effects of interferon-gamma and MHC class I surface antigen levels on resistance of the K562 tumor cell line to natural killer-mediated lysis.
Maziarz RT; Mentzer SJ; Burakoff SJ; Faller DV
Cell Immunol; 1990 Oct; 130(2):329-38. PubMed ID: 2119892
[TBL] [Abstract][Full Text] [Related]
13. Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression.
Zimmer J; Donato L; Hanau D; Cazenave JP; Moretta A; Tongio MM; de la Salle H
Eur J Immunol; 1999 Apr; 29(4):1286-91. PubMed ID: 10229096
[TBL] [Abstract][Full Text] [Related]
14. The role of beta-2 microglobulin in temperature-sensitive and interferon-gamma-induced exocytosis of HLA class I molecules.
Tatake RJ; Ferrone S; Zeff RA
Transplantation; 1992 Sep; 54(3):395-403. PubMed ID: 1412716
[TBL] [Abstract][Full Text] [Related]
15. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.
Ljunggren HG; Sturmhöfel K; Wolpert E; Hämmerling GJ; Kärre K
J Immunol; 1990 Jul; 145(1):380-6. PubMed ID: 2113557
[TBL] [Abstract][Full Text] [Related]
16. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
Menier C; Riteau B; Carosella ED; Rouas-Freiss N
Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
[TBL] [Abstract][Full Text] [Related]
17. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
18. The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles.
Pende D; Accame L; Pareti L; Mazzocchi A; Moretta A; Parmiani G; Moretta L
Eur J Immunol; 1998 Aug; 28(8):2384-94. PubMed ID: 9710216
[TBL] [Abstract][Full Text] [Related]
19. General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect.
Ciccone E; Pende D; Nanni L; Di Donato C; Viale O; Beretta A; Vitale M; Sivori S; Moretta A; Moretta L
Int Immunol; 1995 Mar; 7(3):393-400. PubMed ID: 7794819
[TBL] [Abstract][Full Text] [Related]
20. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2).
Ciccone E; Pende D; Viale O; Than A; Di Donato C; Orengo AM; Biassoni R; Verdiani S; Amoroso A; Moretta A
J Exp Med; 1992 Oct; 176(4):963-71. PubMed ID: 1328466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]